journal article·2020-09-14Open access

Antiviral Nanostructured Surfaces Reduce the Viability of SARS-CoV-2

Jafar Hasan, Alyssa Pyke, Neelima Nair, Tejasri Yarlagadda, Geoffrey Will, Kirsten Spann, Prasad K.D.V. Yarlagadda

Abstract

In this letter, we report the ability of the nanostructured aluminum Al 6063 alloy surfaces to inactivate the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There was no recoverable viable virus after 6 h of exposure to the nanostructured surface, elucidating a 5-log reduction compared to a flat Al 6063 surface. The nanostructured surfaces were fabricated using wet-etching techniques which generated nanotextured, randomly aligned ridges approximately 23 nm wide on the Al 6063 alloy surfaces. In addition to the excellent mechanical resilience properties previously shown, the etched surfaces have also demonstrated superior corrosion resistance compared to the control surfaces. Such nanostructured surfaces have the potential to be used in healthcare environment such as hospitals and public spaces to reduce the surface transmission of SARS-CoV-2 and combat COVID-19.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Infection Control and Ventilation · SARS-CoV-2 detection and testing · SARS-CoV-2 and COVID-19 Research

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Centre for Biomedical Technologies, Science and Engineering Faculty, Queensland University of Technology, Brisbane, Queensland 4000, Australia

Public Health Virology Laboratory, Forensic and Scientific Services, Coopers Plains, Queensland 4108, Australia

Centre for Immunology and Infection Control, Faculty of Health, School of Biomedical Sciences, Queensland University of Technology, Brisbane Queensland 4000, Australia

Funding

Australian Research Council

References (13)

Show source-provided references
1. 10.1128/AEM.02051-0610.1128/AEM.02051-06 ↗
2. 10.3390/v1202013510.3390/v12020135 ↗
3. 10.1016/j.jhin.2020.01.02210.1016/j.jhin.2020.01.022 ↗
4. 10.1001/jama.2020.322710.1001/jama.2020.3227 ↗
5. 10.1021/acsbiomaterials.0c0034810.1021/acsbiomaterials.0c00348 ↗
6. 10.17504/protocols.io.bcduis6w10.17504/protocols.io.bcduis6w ↗
7. 10.1056/NEJMc200497310.1056/NEJMc2004973 ↗
8. 10.1039/C8TB03295E10.1039/C8TB03295E ↗
9. 10.1039/C7NR04176D10.1039/C7NR04176D ↗
10. 10.1016/j.jmbbm.2018.02.01110.1016/j.jmbbm.2018.02.011 ↗
11. 10.1039/C7NR05881K10.1039/C7NR05881K ↗
12. 10.1021/acsbiomaterials.9b0021710.1021/acsbiomaterials.9b00217 ↗
13. Davis J. R. · 1993